Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Impact of hydroxyurea on clinical and biological parameters of sickle cell anemia in children in Abidjan

    MIREILLE YAYO- AYE, Adia Eusèbe Adjambri, Boidy Kouakou, Rebecca N'guessan-Blao, Louis Missa Adjé, Taïratou Kamagaté, Vincent Yapo, Duni Sawadogo
    e2024026
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.026
    823
    PDF: 1182
    HTML: 106
  • Late-Onset Veno-Occlusive Disease (VOD) Post-Haploidentical Transplant: A Diagnostic Challenge Requiring Liver Biopsy– A Case Report

    Mehak Trehan, Homdutt Sharma, Abhinav Sengupta, Anirudh Burli, Pradeep Kumar, Manoranjan Mahapatra
    e2025068
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.068
    1065
    PDF: 540
    Html: 169
  • EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

    Mehrez Mehrez M. Jadaon
    e2011037
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.037
    3219
    PDF: 872
    HTML: 12961
  • SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

    Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs
    e2024006
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.006
    1305
    PDF: 1358
    HTML: 268
  • ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS

    Junyue Cao, YuChao Sun
    e2025060
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.060
    1036
    PDF: 616
    Html: 313
    Suppl. Files: 201
  • CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Rafael de la Camara
    e2016031
    2016-06-20
    https://doi.org/10.4084/mjhid.2016.031
    4968
    PDF: 1879
    HTML: 2872
    Untitled: 274
  • Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

    Shahrzad Zonoozi
    e2017004
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.004
    3060
    PDF: 1030
    HTML: 1306
  • PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

    Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel
    e2020072
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.072
    1316
    PDF: 835
    HTML: 405
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    924
    PDF: 595
    HTML: 2472
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1869
    PDF: 1043
    HTML: 412
  • KINETICS AND ROLE OF PANCREATIC STONE PROTEIN AND MIDREGIONAL PROADRENOMEDULLIN AS PREDICTORS OF SEPSIS AND BACTEREMIA IN CHILDREN WITH HAEMATOLOGICAL MALIGNANCIES.

    Vasiliki Antari, Lemonia Skoura, Athanasios Tragiannidis, Emmanuel Hatzipantelis, Vasiliki-Rengina Tsinopoulou, Konstantina Papakonstantinou, Efthimia Protonotariou, Assimina Galli-Tsinopoulou
    e2023065
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.065
    1042
    PDF: 810
    HTML: 189
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3900
    PDF: 1129
    HTML: 2554
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1732
    PDF: 692
    HTML: 2448
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4328
    PDF: 1288
    HTML: 1430
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1792
    PDF: 754
    HTML: 2977
  • Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

    Monica Carpenedo, Dr, Dr, Dr
    e2023021
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.021
    1308
    PDF: 1201
    HTML: 735
  • PERCEPTION OF COMMUNITY HEALTH CARE WORKERS ABOUT PATIENTS WITH SICKLE CELL DISEASE IN PRIMARY HEALTH CARE AFTER AN EDUCATIONAL INTERVENTION

    Ludmila Mourão Xavier Gomes, Marcos Borato Viana, Igor Alcântara Pereira
    22015031
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.031
    2321
    PDF: 1028
    HTML: 1668
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5439
    PDF: 2018
    HTML: 2205
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    2392
    PDF: 786
    HTML: 2152
    Untitled: 268
    Untitled: 188
    Untitled: 223
    Untitled: 199
    Untitled: 214
    Untitled: 230
    Untitled: 227
  • COINCIDENCE OR CONNECTION? REVISITING THE RELATIONSHIP BETWEEN MASTOCYTOSIS AND LYMPHOMA

    Antonio Frolli, Cristina Papayannidis, Carmen Fava, Martina Bullo, Selene Grano, Valentina Bonuomo, Daniela Gottardi, Guido Parvis, Beatrice Casadei, Daniela Cilloni
    e2026047
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.047
    343
    PDF: 284
    HTML: 43
  • Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

    Anna Candoni
    e2017058
    2017-10-16
    https://doi.org/10.4084/mjhid.2017.058
    3084
    PDF: 941
    HTML: 1445
    Fig.1: 212
    Fig.2: 214
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1555
    PDF: 1483
    HTML: 219
  • Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    e2022060
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.060
    829
    PDF: 502
    HTML: 226
  • HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases

    Donato Rigante, Helena Pelanda, Eleonora Rulli, Murad Sultanov, Susanna Adornato
    e2026025
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.025
    1210
    PDF: 880
    HTML: 296
  • Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

    Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile
    e2023061
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.061
    939
    PDF: 503
    HTML: 215
  • ON THE VERSATILITY OF VON WILLEBRAND FACTOR

    Antoine Rauch, Peter Lenting
    e2013046
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.046
    2956
    PDF: 1211
    HTML: 11426
  • A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

    Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo
    e2025033
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.033
    954
    PDF: 748
    HTML: 205
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    1095
    PDF: 1292
    HTML: 135
  • Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

    Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc
    e2012018
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.018
    1732
    PDF: 871
    HTML: 1252
  • ADVANCES IN THE TREATMENT OF MALARIA

    Francesco Castelli, Lina Rachele Tomasoni, Alberto Matteelli
    e2012064
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.064
    2952
    PDF: 1359
    HTML: 6150
  • COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

    Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast
    e2022032
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.032
    1201
    PDF: 602
    HTML: 269
  • PREGNANCY LOSS IN WOMEN WITH HIV IS NOT ASSOCIATED WITH HIV MARKERS: DATA FROM A NATIONAL STUDY IN ITALY, 2001-2018

    Marco Floridia, Giulia Masuelli, Beatrice Tassis, Enrica Tamburrini, Valeria Savasi, Matilde Sansone, Arsenio Spinillo, Giuseppina Liuzzi, Anna Degli Antoni, Serena Dalzero, Laura Franceschetti, Giuliana Simonazzi, Gianpaolo Maso, Daniela Francisci, Carmela Pinnetti, Marina Ravizza
    e2019050
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.050
    1391
    PDF: 959
    HTML: 265
  • CYTOKINE RESPONSE ASSOCIATED WITH HEPATITIS C VIRUS CLEARANCE IN HIV COINFECTED PATIENTS INITIATING PEG INTERFERON-? BASED THERAPY.

    Truong Tam Nguyen, Reihani Niloofar, Pierre-Alain Rubbo, Kuster Nils, Karine Bollore, Jacques Ducos, Georges-Philippe Pageaux, Jacques Reynes, Philippe Van de Perre, Edouard Tuaillon
    e2016003
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.003
    3265
    PDF: 983
    HTML: 2182
    Untitled: 211
  • Direct oral anticoagulants (DOACs) in the onco-hematologic patients

    Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2025022
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.022
    1175
    PDF: 1076
    HTML: 163
  • FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients

    Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni
    e2024066
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.066
    1114
    PDF: 664
    Html: 180
  • GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload

    Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis , Salvatore Di Maio, Christos Kattamis
    e2023006
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.006
    4090
    PDF: 1197
    HTML: 473
  • LEVOFLOXACIN PROPHYLAXIS VERSUS NO PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA DURING POST-INDUCTION APLASIA: A SINGLE CENTER STUDY

    Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio
    e2023022
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.022
    1843
    PDF: 1159
    HTML: 427
  • Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia

    Tuba Gullu koca, Ahmet Mert Yanik
    e2026069
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.069
    92
    PDF: 82
    Html: 16
  • Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia

    Kun Yang
    e2025037
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.037
    976
    PDF: 795
    HTML: 272
  • WHAT ARE FUNGAL INFECTIONS?

    Ben E de Pauw
    e2011001
    2011-01-03
    https://doi.org/10.4084/mjhid.2011.001
    4389
    PDF: 2501
    HTML: 27705
    de Pauw: 281
  • ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Murat Akova
    e2017002
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.002
    4200
    PDF: 1320
    HTML: 2122
    Table 1: 232
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    1153
    PDF: 804
    HTML: 145
  • ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

    Karim Massaro, Silvia F Costa
    e2015059
    2015-10-15
    https://doi.org/10.4084/mjhid.2015.059
    2261
    PDF: 1054
    HTML: 1816
  • Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

    Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena
    e2016016
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.016
    2979
    PDF: 742
    HTML: 1968
    figure 1: 211
    figure 2: 214
  • IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)

    Maria Concetta Renda, Aurelio Maggio
    e2009031
    2009-12-29
    1343
    PDF: 498
    HTML: 1035
  • ASSOCİATİON BETWEEN IRON OVERLOAD AND GLUCOSE METABOLİSM İN CHİLDREN AND YOUTH WİTH TRANSFUSİON-DEPENDENT BETA THALASSEMİA: THE ROLE OF CHELATİON THERAPY

    Deniz Guven, Dr. İncefidan, Dr. Kazanci, Dr. Ozlem Kara
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.017
    788
    PDF: 714
    HTML: 176
  • Isavuconazole successfully treated pulmonary mucormycosis in acute myeloid leukemia: A case report

    Hong Chen, Kun Chen, wenqiang kong
    e2025031
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.031
    970
    PDF: 805
    HTML: 201
  • PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

    Fiorina Giona
    e2021069
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.069
    2042
    HTML: 1681
    PDF: 1184
  • EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

    Pellegrino Musto, Dr. Nicola Sgherza
    e2024073
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.073
    1649
    PDF: 877
    HTML: 276
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1681
    PDF: 678
    HTML: 7210
201 - 250 of 263 items << < 1 2 3 4 5 6 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.